Edit

MPM

http://mpmproducts.co.uk/

Last activity: 02.05.2024

Active

Categories: B2CFoodTechGrowthMarketPet

Macclesfield-based MPM produces high-quality, natural pet foods for discerning cat and dog owners. Within the global pet food market, estimated to be worth £50 billion, the premium niche has been taking market share, helping to drive market value growth in an otherwise low growth category.

Mentions

Investors 1

Date	Name	Website
-	ECI Partne...	ecipartner...

Mentions in press and media 23

Date	Title	Description
02.05.2024	MPM BioImpact-owned Reunion raises $103M, one of the largest rounds for a psychedelic biotech	It’s taken decades for psychedelics to regain clinical and regulatory relevance. But, in just a matter of months, progress has accelerated, with a biotech raising one of the largest private rounds ever for the field. Reunion Neuroscience ha...
01.06.2023	Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact	-
06.10.2021	MPM Capital Raises $850 Million to Fund Cancer Drug Firms MPM Capital Raises $850 Million to Fund Cancer Drug Firms	-
27.02.2020	MPM Capital raises $100m Oncology Innovations Fund	Healthcare venture firm MPM Capital has raised $100m for its MPM Oncology Innovations Fund, in collaboration with the D
26.02.2020	MPM gains first offer on Dana-Farber tech, raises $100M fund W h i t e p a p e r Weighing the Costs:	MPM Capital and Dana-Farber Cancer Institute have formed a venture philanthropy alliance, raising a $100 million investment fund and $26 million in donations to support early stage research. Sponsored by Agilent Technologies How would you l...
20.11.2019	MPM and Longwood-backed Werewolf Therapeutics grabs $56 million to take tumors by night	Backed with the team from his last company, one of the key developers behind Keytruda has a new warchest in the race to bring immunotherapy into the tumor micro-environment. Dan Hicklin, who oversaw Merck’s I/O portfol...
22.02.2019	MPM Capital raises $400M in seventh venture fund	“Over two decades of investing, MPM has developed long-standing and strategic partners with academia, biotech and large pharma,” MPM co-founder Luke Evnin said in a statement. “Vital to our objective of delivering new treatments to improve ...
21.02.2019	MPM Capital Raises $400 Million to Fund Early-Stage Biotech Innovation	-
21.02.2019	MPM Capital Raises $400 Million	CAMBRIDGE, Mass. & BRISBANE, Calif.--(BUSINESS WIRE)--MPM Capital, a life-sciences venture capital firm investing in early-stage therapeutics companies, announced today the closing of its seventh venture fund, BioVentures 2018 (BV2018)....
21.02.2019	MPM Capital closes bioventure fund on $400m	Healthcare-focused VC MPM Capital has ended its seventh fundraise after pulling in $400m for its BioVentures 2018 vehic
21.02.2019	MPM Capital secures $400M treasure chest for early biotechs W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory Compliance	Life science VC MPM Capital is looking to boost funding for a select series of early-stage biotechs with a new $400 million fund. Sponsored by Agilent Technologies How would you like to win free bench space at Lab Central for one scientist ...
21.02.2019	Scrip Pharma intelligence: MPM Raises $400M To Build Early-Stage Biotechs	-
21.02.2019	MPM Capital secures $400M treasure chest for early biotechs	Life science VC MPM Capital is looking to boost funding for a select series of early-stage biotechs with a new $400 million fund. This cash injection comes from its seventh venture fund, known as BioVentures 2018 (aka BV2018), and sits alon...
18.04.2018	MPM Capital Portfolio Company Tetherex Pharmaceuticals Completes $50M Series B Financing	-
16.04.2018	MPM and AACR Partnership Featured in Barron’s Article “UBS Oncology Impact Fund Announces $2.5M in Gifts”	-
26.02.2018	MPM Capital launches BioVentures 2018 vehicle, eyes up to $400m	Early-stage investment house MPM Capital has launched a new fund and is eyeing up to $400m. MPM BioVentures 2018 has not
03.05.2016	MPM Launches $471 Million Social Impact Oncology Fund	-
14.05.2015	MPM closes $400 million fund	-
06.03.2007	MPM Capital closes $550m BioVentures IV healthcare venture fund	MPM Capital, a US-based investment management firm focused solely on healthcare investing, has closed MPM BioVentures IV
05.03.2007	MPM Capital raises $550M healthcare fund	MPM Capital, a large venture firm with offices in Boston, San Francisco and New York, said it has raised a new $550 million fund, to focus mostly on biotech and specialty pharma companies, but with 15 percent earmarked for other medical com...
09.12.2002	MPM Capital announces fund close of MPM Bioventures III at $900m	The fund’s original target was $750m, but the firm announced in early September that it would be setting a cap of
07.01.2002	MPM Capital closes biotech fund at $450m	The fund will invest mainly in publicly traded biotechnology stocks to compliment the $800m it manages in its BioVenture
-	MPM Capital raises $400M in seventh venture fund	A life sciences-focused venture capital firm based near Boston has raised more than one-third of a billion dollars to invest in early-stage companies. Cambridge, Massachusetts-based MPM Capital said Thursday that it had raised $400 million ...

MPM

Investors 1

Mentions in press and media 23

Reviews 0